Nurix’s $120m Venture Round Will Bring Two Protein-Modulating Therapies To Clinic

 
• By Joseph Haas
  
Funding Economy FInancial Collection Fund Concept
A $120m financing should enable Nurix to get two programs into clinical development
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business